Evropska unija - slovenščina - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastična sredstva - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed  after at least one prior line of systemic therapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - drugi dermatološki preparati - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Evropska unija - slovenščina - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. glej poglavja 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.

Evropska unija - slovenščina - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pekana naturheilmittel gmbh - argentum nitricum; ailanthus altissima; vincetoxicum hirundaria; marrubium vulgare; nasturtium officinale; cinchona pubescens spag. peka (china); lachesis muta; echinacea spag. peka - peroralne kapljice, raztopina - argentum nitricum 6 d / 1 ml  ailanthus altissima3 d / 1 ml  vincetoxicum hirundaria6 d / 1 ml  marrubium vulgare6 d / 1 ml  nasturtium officinale6 d / 1 ml  cinchona pubescens spag. peka (china)8 d / 1 ml  lachesis muta12 d / 1 ml  echinacea spag. peka12 d / 1 ml; ailanthus altissima 3 d / 1 ml  vincetoxicum hirundaria6 d / 1 ml  marrubium vulgare6 d / 1 ml  nasturtium officinale6 d / 1 ml  cinchona pubescens spag. peka (china)8 d / 1 ml  lachesis muta12 d / 1 ml  echinacea spag. peka12 d / 1 ml; vincetoxicum hirundaria 6 d / 1 ml  marrubium vulgare6 d / 1 ml  nasturtium officinale6 d / 1 ml  cinchona pubescens spag. peka (china)8 d / 1 ml  lachesis muta12 d / 1 ml  echinacea spag. peka12 d / 1 ml; marrubium vulgare 6 d / 1 ml  nasturtium officinale6 d / 1 ml  cinchona pubescens spag. peka (china)8 d / 1 ml  lachesis muta12 d / 1 ml  echinacea spag. peka12 d / 1 ml; nasturtium officinale 6 d / 1 ml  cinchona pubescens spag. peka (china)8 d / 1 ml  lachesis muta12 d / 1 ml  echinacea spag. peka12 d / 1 ml; cinchona pubescens spag. peka (china) 8 d / 1 ml  lachesis muta12 d / 1 ml  echinacea spag. peka12 d / 1 ml; lachesis muta 12 d / 1 ml  echinacea spag. peka12 d / 1 ml; echinacea spag. peka 12 d / 1 ml - -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pekana naturheilmittel gmbh - argentum nitricum; ailanthus altissima; vincetoxicum hirundaria; marrubium vulgare; nasturtium officinale; cinchona pubescens spag. peka (china); lachesis muta; echinacea spag. peka - kroglica - argentum nitricum 6 d / 1 g  ailanthus altissima3 d / 1 g  vincetoxicum hirundaria6 d / 1 g  marrubium vulgare6 d / 1 g  nasturtium officinale6 d / 1 g  cinchona pubescens spag. peka (china)8 d / 1 g  lachesis muta12 d / 1 g  echinacea spag. peka12 d / 1 g; ailanthus altissima 3 d / 1 g  vincetoxicum hirundaria6 d / 1 g  marrubium vulgare6 d / 1 g  nasturtium officinale6 d / 1 g  cinchona pubescens spag. peka (china)8 d / 1 g  lachesis muta12 d / 1 g  echinacea spag. peka12 d / 1 g; vincetoxicum hirundaria 6 d / 1 g  marrubium vulgare6 d / 1 g  nasturtium officinale6 d / 1 g  cinchona pubescens spag. peka (china)8 d / 1 g  lachesis muta12 d / 1 g  echinacea spag. peka12 d / 1 g; marrubium vulgare 6 d / 1 g  nasturtium officinale6 d / 1 g  cinchona pubescens spag. peka (china)8 d / 1 g  lachesis muta12 d / 1 g  echinacea spag. peka12 d / 1 g; nasturtium officinale 6 d / 1 g  cinchona pubescens spag. peka (china)8 d / 1 g  lachesis muta12 d / 1 g  echinacea spag. peka12 d / 1 g; cinchona pubescens spag. peka (china) 8 d / 1 g  lachesis muta12 d / 1 g  echinacea spag. peka12 d / 1 g; lachesis muta 12 d / 1 g  echinacea spag. peka12 d / 1 g; echinacea spag. peka 12 d / 1 g - -

Evropska unija - slovenščina - EMA (European Medicines Agency)

dompé biotec s.p.a. - darbepoetin alfa - kidney failure, chronic; anemia; cancer - antianemični preparati - zdravljenje simptomatske anemije, povezane s kronično odpovedjo ledvic (crf) pri odraslih in pediatričnih bolnikih. zdravljenje simptomatsko anemija pri odraslih bolnikov z rakom z non-mieloično malignancies, ki prejemajo kemoterapijo.

Evropska unija - slovenščina - EMA (European Medicines Agency)

intervet international bv - azagly-nafarelin - hipofize in hipotalamični hormoni in analogi - dogs; salmonidae (salmonid fish) - Ženski salmonidne ribe kot atlantski losos (salmo salar), šarenka (oncorhynchus mykiss), potočna postrv (salmo trutta) in arktične charr (salvelinus alpinus)indukcije in sinhronizacija ovulacije za proizvodnjo eyed-jajca in fry. psi (psice)preprečevanje gonadno funkcijo v psice prek dolgoročno blokade za sintezo gonadotrophin.

Evropska unija - slovenščina - EMA (European Medicines Agency)

roche registration ltd. - daclizumab - graft rejection; kidney transplantation - imunosupresivi - zenapax je indicirano za preventivo, akutno organov zavrnitve v de novo proti alogensko presaditev ledvic in je namenjeno sočasno z imunosupresivnimi režim, pri bolnikih, ki niso zelo imuniziranih vključno ciklosporin in kortikosteroidi.

Evropska unija - slovenščina - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - palifermin - mucositis - vsi drugi terapevtski izdelki - kepivance je indicirano za zmanjšanje pogostosti, trajanje in resnost ustni mukolitis pri odraslih bolnikih z hematološke maligne prejemajo myeloablative pooperativne radioterapije, povezane z visoko incidenco hudo mukolitis in zahteva podporo avtologni-hematopoetske-izvornih celic.